Can hantavirus be transmitted human-to-human, and which strains (e.g., Andes virus) require droplet/contact isolation precautions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Human-to-Human Hantavirus Transmission

Most hantaviruses do NOT transmit between humans, with the critical exception of Andes virus (ANDV), which requires droplet and contact precautions for suspected or confirmed cases.

Transmission Patterns by Virus Type

Old World Hantaviruses (HFRS-causing)

  • No person-to-person transmission documented 1
  • Standard precautions are sufficient
  • Transmission occurs exclusively through rodent exposure

New World Hantaviruses - United States

  • No person-to-person transmission for Sin Nombre virus and other North American strains 1
  • Despite genetic similarity to Andes virus and comparable mortality (~40%), Sin Nombre virus does not spread between humans 2
  • Standard precautions are adequate

Andes Virus (ANDV) - South America

This is the only hantavirus with confirmed human-to-human transmission 1. The evidence is compelling:

  • Well-documented nosocomial transmission in southern Argentina outbreak 1
  • Confirmed household transmission 3
  • Healthcare worker infections after direct patient contact 3
  • Transmission through respiratory secretions and saliva 4
  • Documented mother-to-child transmission via breast milk 5

Clinical Isolation Requirements

For Andes Virus Cases (Confirmed or Suspected)

Implement droplet and contact precautions immediately:

  • Personal protective equipment: N95 respirator or equivalent, gown, gloves, eye protection
  • Patient placement: Private room with negative pressure if available
  • Duration: Maintain precautions for 42 days from symptom onset or exposure 3
  • Healthcare worker monitoring: All exposed personnel require 42-day surveillance for symptoms 3

Mechanism of Person-to-Person Spread

The virus replicates in:

  • Alveolar epithelial cells with viral particles discharged into alveolar lumen 4
  • Lung macrophages that can reach airways and be expectorated 4
  • Salivary gland secretory cells with virus in saliva 4

Critical Pitfalls to Avoid

Geographic assumption error: Do not assume all hantavirus cases require isolation. Only ANDV (endemic to Chile and Argentina) transmits person-to-person 1, 2.

Incubation period miscalculation: Person-to-person transmission has a shorter incubation period than environmental exposure. Monitor all contacts for 42 days, not the typical environmental exposure period 3.

Inadequate precautions: Standard precautions are insufficient for ANDV. Healthcare workers have been infected despite limited contact 3.

Evidence Quality Assessment

The CDC guidelines 1 provide the authoritative framework, clearly distinguishing ANDV from other hantaviruses. While a 2022 systematic review 6 questioned the evidence quality for human-to-human transmission, this review had methodological limitations and conflicts with multiple well-documented outbreak investigations 3 and biological evidence 4, 5. The preponderance of evidence, including molecular sequencing, epidemiologic investigation, and ultrastructural studies, supports person-to-person transmission of ANDV specifically.

For practical clinical decision-making: If the patient has potential exposure in Chile or Argentina, treat as ANDV and implement full isolation precautions. If exposure occurred in North America or other regions, standard precautions suffice 1, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.